id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
---|---|---|---|---|---|
NCT02352025 | 15:28:cancer | All stages of breast cancer | 1 | [
"All",
"stages",
"of",
"breast",
"cancer"
] | [
0,
0,
0,
3,
3
] |
NCT00975520 | 10:31:treatment | Complete macroscopic resection of all known disease | 1 | [
"Complete",
"macroscopic",
"resection",
"of",
"all",
"known",
"disease"
] | [
0,
1,
1,
0,
0,
0,
0
] |
NCT02501954 | 20:30:cancer, | evidence of active malignancy within the last five years | 1 | [
"evidence",
"of",
"active",
"malignancy",
"within",
"the",
"last",
"five",
"years"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT00542373 | 43:56:chronic_disease,58:72:chronic_disease,129:140:cancer | Persons with any other condition (such as lichen planus, Fanconi anemia, heavy tobacco use, etc) making them at higher risk for oral cancer development | 1 | [
"Persons",
"with",
"any",
"other",
"condition",
"(",
"such",
"as",
"lichen",
"planus",
",",
"Fanconi",
"anemia",
",",
"heavy",
"tobacco",
"use",
",",
"etc",
")",
"making",
"them",
"at",
"higher",
"risk",
"for",
"oral",
"cancer",
"development"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0
] |
NCT02801136 | 84:88:chronic_disease | Family member (parent if a minor) willing to participate and that the subject with PNES chooses | 1 | [
"Family",
"member",
"(",
"parent",
"if",
"a",
"minor",
")",
"willing",
"to",
"participate",
"and",
"that",
"the",
"subject",
"with",
"PNES",
"chooses"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT01446094 | 24:44:treatment | Scheduled for invasive coronary angiography | 1 | [
"Scheduled",
"for",
"invasive",
"coronary",
"angiography"
] | [
0,
0,
0,
1,
1
] |
NCT02796391 | 1:20:chronic_disease | Fluvoxamine (Luvox) | 1 | [
"Fluvoxamine",
"(",
"Luvox",
")"
] | [
2,
2,
0,
0
] |
NCT02446457 | ,,,,,,,,,,,,,396:405:treatment | Serum creatinine OR measured or calculated creatinine clearance (glomerular filtration rate [GFR] can also be used in place of creatinine or creatinine clearance [CrCl]) (creatinine clearance will be calculated per institutional standard) =< 1.5 x upper limit of normal (ULN) OR >= 60 mL/min GFR or CrCl for subjects with creatinine levels > 1.5 x institutional ULN, performed within 28 days of treatment initiation | 1 | [
"Serum",
"creatinine",
"OR",
"measured",
"or",
"calculated",
"creatinine",
"clearance",
"(",
"glomerular",
"filtration",
"rate",
"[",
"GFR",
"]",
"can",
"also",
"be",
"used",
"in",
"place",
"of",
"creatinine",
"or",
"creatinine",
"clearance",
"[",
"CrCl",
"]",
")",
"(",
"creatinine",
"clearance",
"will",
"be",
"calculated",
"per",
"institutional",
"standard",
")",
"=",
"<",
"1.5",
"x",
"upper",
"limit",
"of",
"normal",
"(",
"ULN",
")",
"OR",
">",
"=",
"60",
"mL/min",
"GFR",
"or",
"CrCl",
"for",
"subjects",
"with",
"creatinine",
"levels",
">",
"1.5",
"x",
"institutional",
"ULN",
",",
"performed",
"within",
"28",
"days",
"of",
"treatment",
"initiation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02570984 | 1:17:treatment | thoracic surgery | 1 | [
"thoracic",
"surgery"
] | [
1,
1
] |
NCT02015390 | 1:71:chronic_disease | Ipsilateral extremity defect (eg, tibia and femur ipsilateral defects) | 1 | [
"Ipsilateral",
"extremity",
"defect",
"(",
"eg",
",",
"tibia",
"and",
"femur",
"ipsilateral",
"defects",
")"
] | [
2,
2,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0
] |
NCT03069911 | 62:93:chronic_disease | meet Diagnostic and Statistical Manual (DSM)-IV criteria for major depressive disorder (MDD) as diagnosed by the M.I.N.I. at screening | 1 | [
"meet",
"Diagnostic",
"and",
"Statistical",
"Manual",
"(",
"DSM",
")",
"-IV",
"criteria",
"for",
"major",
"depressive",
"disorder",
"(",
"MDD",
")",
"as",
"diagnosed",
"by",
"the",
"M.I.N.I",
".",
"at",
"screening"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02531711 | 8:17:treatment,55:65:cancer,67:77:chronic_disease,79:105:chronic_disease | Active treatment for a major medical illness, such as malignancy, autoimmune, immune deficiency disorder | 1 | [
"Active",
"treatment",
"for",
"a",
"major",
"medical",
"illness",
",",
"such",
"as",
"malignancy",
",",
"autoimmune",
",",
"immune",
"deficiency",
"disorder"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
2,
0,
2,
2,
2
] |
NCT02075671 | 8:32:treatment, | Use of systemic corticosteroids 3 months prior to Visit 1 | 1 | [
"Use",
"of",
"systemic",
"corticosteroids",
"3",
"months",
"prior",
"to",
"Visit",
"1"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT00258427 | 1:16:chronic_disease,,,,,,, | Aplastic anemia is defined as having at least one of the following (with or without cytogenetic abnormalities): platelet count <20 * 10^9, - absolute neutrophil count (ANC) <5 * 10^8/L, - Hgb <8 g/dL / | 1 | [
"Aplastic",
"anemia",
"is",
"defined",
"as",
"having",
"at",
"least",
"one",
"of",
"the",
"following",
"(",
"with",
"or",
"without",
"cytogenetic",
"abnormalities",
")",
":",
"platelet",
"count",
"<",
"20",
"*",
"10^9",
",",
"-",
"absolute",
"neutrophil",
"count",
"(",
"ANC",
")",
"<",
"5",
"*",
"10^8/L",
",",
"-",
"Hgb",
"<",
"8",
"g/dL",
"/"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02505165 | 57:67:cancer | The diagnosis is determined to be a relapse or a second malignancy | 1 | [
"The",
"diagnosis",
"is",
"determined",
"to",
"be",
"a",
"relapse",
"or",
"a",
"second",
"malignancy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT02628535 | 1:21:cancer,23:40:cancer,,,46:62:treatment | pleural mesothelioma, pancreatic cancer: 1-3 prior treatments | 1 | [
"pleural",
"mesothelioma",
",",
"pancreatic",
"cancer",
":",
"1-3",
"prior",
"treatments"
] | [
3,
3,
0,
3,
3,
0,
0,
1,
1
] |
NCT02516241 | 1:17:chronic_disease,28:40:chronic_disease,42:53:chronic_disease,55:66:chronic_disease,71:105:chronic_disease | Active infection including tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) | 1 | [
"Active",
"infection",
"including",
"tuberculosis",
",",
"hepatitis",
"B",
",",
"hepatitis",
"C",
",",
"or",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] | [
2,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT03040778 | 17:37:chronic_disease | Patients with a vitamin K deficiency due to any cause | 1 | [
"Patients",
"with",
"a",
"vitamin",
"K",
"deficiency",
"due",
"to",
"any",
"cause"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02995590 | 1:15:chronic_disease,17:35:treatment,37:45:chronic_disease,100:109:treatment,139:150:treatment | Claustrophobia, inner ear implants, aneurysm or other surgical clips, metal foreign bodies in eye, pacemaker or other contraindication to MR scanning | 1 | [
"Claustrophobia",
",",
"inner",
"ear",
"implants",
",",
"aneurysm",
"or",
"other",
"surgical",
"clips",
",",
"metal",
"foreign",
"bodies",
"in",
"eye",
",",
"pacemaker",
"or",
"other",
"contraindication",
"to",
"MR",
"scanning"
] | [
2,
0,
1,
1,
1,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
1
] |
NCT03000998 | 63:74:treatment | the participant has already received any or all doses for the HPV vaccine | 1 | [
"the",
"participant",
"has",
"already",
"received",
"any",
"or",
"all",
"doses",
"for",
"the",
"HPV",
"vaccine"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02162420 | 1:23:chronic_disease | severe portal fibrosis | 1 | [
"severe",
"portal",
"fibrosis"
] | [
2,
2,
2
] |
NCT02003222 | 47:66:treatment,68:80:treatment,103:122:treatment,123:136:treatment,167:188:treatment | It is recommended to utilize a regimen of the integrase inhibitor, dolutegravir, combined with either disoproxil fumarate/emtricitabine or dolutegravir combined with tenofovir alafenamide/emtricitabine | 1 | [
"It",
"is",
"recommended",
"to",
"utilize",
"a",
"regimen",
"of",
"the",
"integrase",
"inhibitor",
",",
"dolutegravir",
",",
"combined",
"with",
"either",
"disoproxil",
"fumarate/emtricitabine",
"or",
"dolutegravir",
"combined",
"with",
"tenofovir",
"alafenamide/emtricitabine"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1
] |
NCT00914628 | 22:33:chronic_disease | Patients with active CNS disease | 1 | [
"Patients",
"with",
"active",
"CNS",
"disease"
] | [
0,
0,
0,
2,
2
] |
NCT02588326 | 12:22:cancer, | History of malignancy within the past five years | 1 | [
"History",
"of",
"malignancy",
"within",
"the",
"past",
"five",
"years"
] | [
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT03113695 | 17:27:cancer | Patients with a malignancy that has been treated, but not with curative intent | 1 | [
"Patients",
"with",
"a",
"malignancy",
"that",
"has",
"been",
"treated",
",",
"but",
"not",
"with",
"curative",
"intent"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02988895 | ,,76:79:chronic_disease,81:113:chronic_disease,126:144:chronic_disease | Fellow eye with a BCVA of 20/63 Snellen Equivalent or worse, with advanced AMD (neovascular or non-exudative AMD with foveal geographic atrophy) | 1 | [
"Fellow",
"eye",
"with",
"a",
"BCVA",
"of",
"20/63",
"Snellen",
"Equivalent",
"or",
"worse",
",",
"with",
"advanced",
"AMD",
"(",
"neovascular",
"or",
"non-exudative",
"AMD",
"with",
"foveal",
"geographic",
"atrophy",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
2,
2,
0
] |
NCT00412594 | 1:19:treatment, | Prior chemotherapy (last 4 weeks) | 1 | [
"Prior",
"chemotherapy",
"(",
"last",
"4",
"weeks",
")"
] | [
1,
1,
0,
0,
0,
0,
0
] |
NCT02158858 | 4:29:treatment | No prior treatment with JAKi allowed | 1 | [
"No",
"prior",
"treatment",
"with",
"JAKi",
"allowed"
] | [
0,
1,
1,
1,
1,
0
] |
NCT02508038 | 15:24:cancer,28:43:cancer,74:81:treatment,89:101:treatment | Relapsed with pulmonary or bone metastases and did not achieve a CR with surgery and/or chemotherapy | 1 | [
"Relapsed",
"with",
"pulmonary",
"or",
"bone",
"metastases",
"and",
"did",
"not",
"achieve",
"a",
"CR",
"with",
"surgery",
"and/or",
"chemotherapy"
] | [
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT03112824 | 1:21:chronic_disease | Oral Corticosteroids | 1 | [
"Oral",
"Corticosteroids"
] | [
2,
2
] |
NCT02559817 | 28:37:treatment | willing to discontinue any laxatives used before the Pretreatment Visit in favor of the protocol-permitted rescue medicine | 1 | [
"willing",
"to",
"discontinue",
"any",
"laxatives",
"used",
"before",
"the",
"Pretreatment",
"Visit",
"in",
"favor",
"of",
"the",
"protocol-permitted",
"rescue",
"medicine"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01684397 | 12:38:chronic_disease | History of deep vein thrombosis (DVT) | 1 | [
"History",
"of",
"deep",
"vein",
"thrombosis",
"(",
"DVT",
")"
] | [
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT03028012 | 36:41:allergy_name,43:45:allergy_name,50:66:allergy_name | Allergy or contraindication to any NSAID, CS, or local anesthetic | 1 | [
"Allergy",
"or",
"contraindication",
"to",
"any",
"NSAID",
",",
"CS",
",",
"or",
"local",
"anesthetic"
] | [
0,
0,
0,
0,
0,
4,
0,
4,
0,
0,
4,
4
] |
NCT02340156 | 1:18:treatment,9:18:treatment,42:62:treatment, | Planned treatment, or treatment with any investigational drug within 4 weeks prior to screening | 1 | [
"Planned",
"treatment",
",",
"or",
"treatment",
"with",
"any",
"investigational",
"drug",
"within",
"4",
"weeks",
"prior",
"to",
"screening"
] | [
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02465060 | 24:43:chronic_disease | subjects with moderate valvular thickening should not be entered on study | 1 | [
"subjects",
"with",
"moderate",
"valvular",
"thickening",
"should",
"not",
"be",
"entered",
"on",
"study"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT00959140 | 1:24:chronic_disease | Uncontrolled infections, defined as positive blood cultures | 1 | [
"Uncontrolled",
"infections",
",",
"defined",
"as",
"positive",
"blood",
"cultures"
] | [
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02338232 | 1:10:treatment | Melphalan 140 mg/m2 | 1 | [
"Melphalan",
"140",
"mg/m2"
] | [
1,
0,
0
] |
NCT02128906 | 37:61:cancer | with the exception of patients with bilateral tonsil cancers | 1 | [
"with",
"the",
"exception",
"of",
"patients",
"with",
"bilateral",
"tonsil",
"cancers"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT02329327 | 1:15:chronic_disease,,, | Acute bleeding associated with a hemoglobin level of ≤8 g/dL if no baseline hemoglobin is available | 1 | [
"Acute",
"bleeding",
"associated",
"with",
"a",
"hemoglobin",
"level",
"of",
"≤8",
"g/dL",
"if",
"no",
"baseline",
"hemoglobin",
"is",
"available"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03132636 | 24:36:cancer | Confirmed diagnosis of invasive BCC | 1 | [
"Confirmed",
"diagnosis",
"of",
"invasive",
"BCC"
] | [
0,
0,
0,
3,
3
] |
NCT02614365 | 14:26:chronic_disease,28:38:chronic_disease,84:92:chronic_disease | persons with neurological, psychiatry or other clinical conditions likely to cause dementia | 1 | [
"persons",
"with",
"neurological",
",",
"psychiatry",
"or",
"other",
"clinical",
"conditions",
"likely",
"to",
"cause",
"dementia"
] | [
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT01990209 | ,,,163:172:treatment, | Male patients (even those post vasectomy) who are willing to use adequate contraceptive measures or abstain from heterosexual intercourse during the entire study treatment period and for 4 months after the last dose of study drug | 1 | [
"Male",
"patients",
"(",
"even",
"those",
"post",
"vasectomy",
")",
"who",
"are",
"willing",
"to",
"use",
"adequate",
"contraceptive",
"measures",
"or",
"abstain",
"from",
"heterosexual",
"intercourse",
"during",
"the",
"entire",
"study",
"treatment",
"period",
"and",
"for",
"4",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02541565 | ,,,149:159:treatment | Female subject of childbearing potential should have a negative urine or serum pregnancy within 72 hours prior to receiving the first dose of study medication | 1 | [
"Female",
"subject",
"of",
"childbearing",
"potential",
"should",
"have",
"a",
"negative",
"urine",
"or",
"serum",
"pregnancy",
"within",
"72",
"hours",
"prior",
"to",
"receiving",
"the",
"first",
"dose",
"of",
"study",
"medication"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02311361 | 32:40:cancer | Each case will be discussed at GI tumor board with multidisciplinary team | 1 | [
"Each",
"case",
"will",
"be",
"discussed",
"at",
"GI",
"tumor",
"board",
"with",
"multidisciplinary",
"team"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT02346253 | 1:4:chronic_disease,61:120:treatment,,, | HIV-positive patients are eligible, provided they are under treatment with highly active antiretroviral therapy (HAART) and have a CD4 count >= 200 cells/microliter no more than 30 days prior to registration | 1 | [
"HIV-positive",
"patients",
"are",
"eligible",
",",
"provided",
"they",
"are",
"under",
"treatment",
"with",
"highly",
"active",
"antiretroviral",
"therapy",
"(",
"HAART",
")",
"and",
"have",
"a",
"CD4",
"count",
">",
"=",
"200",
"cells/microliter",
"no",
"more",
"than",
"30",
"days",
"prior",
"to",
"registration"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02498613 | ,41:68:treatment,81:89:cancer,93:111:cancer,138:143:cancer,154:159:cancer,155:159:cancer,174:194:treatment,199:231:treatment,239:269:treatment,276:289:treatment,323:327:cancer,369:389:treatment,391:402:treatment,408:438:treatment,462:479:treatment | Must have received at least one line of standard systemic treatment for locally advanced or metastatic disease setting of the respective tumor type; for NSCLC, it is either PD-1/PD-L1 inhibitor, or platinum-containing chemotherapy, or an EGFR tyrosine kinase inhibitor or an ALK inhibitor if sensitizing mutation present; TNBC: platinum-containing chemotherapy; PDAC: fluorouracil (5-FU-), gemcitabine-, or taxane-containing chemotherapy either with or without radiation therapy; SCLC: platinum-containing chemotherapy for limited or extensive stage disease | 1 | [
"Must",
"have",
"received",
"at",
"least",
"one",
"line",
"of",
"standard",
"systemic",
"treatment",
"for",
"locally",
"advanced",
"or",
"metastatic",
"disease",
"setting",
"of",
"the",
"respective",
"tumor",
"type",
";",
"for",
"NSCLC",
",",
"it",
"is",
"either",
"PD-1/PD-L1",
"inhibitor",
",",
"or",
"platinum-containing",
"chemotherapy",
",",
"or",
"an",
"EGFR",
"tyrosine",
"kinase",
"inhibitor",
"or",
"an",
"ALK",
"inhibitor",
"if",
"sensitizing",
"mutation",
"present",
";",
"TNBC",
":",
"platinum-containing",
"chemotherapy",
";",
"PDAC",
":",
"fluorouracil",
"(",
"5-FU-",
")",
",",
"gemcitabine-",
",",
"or",
"taxane-containing",
"chemotherapy",
"either",
"with",
"or",
"without",
"radiation",
"therapy",
";",
"SCLC",
":",
"platinum-containing",
"chemotherapy",
"for",
"limited",
"or",
"extensive",
"stage",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
3,
0,
0,
0,
3,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02553642 | 19:42:chronic_disease,38:41:chronic_disease,105:128:chronic_disease,124:127:chronic_disease,194:220:chronic_disease | Positive test for hepatitis B virus (HBV) using HBV surface antigen (HBV sAg) test or positive test for hepatitis C virus (HCV) using HCV ribonucleic acid (RNA) or HCV antibody test indicating acute or chronic infection | 1 | [
"Positive",
"test",
"for",
"hepatitis",
"B",
"virus",
"(",
"HBV",
")",
"using",
"HBV",
"surface",
"antigen",
"(",
"HBV",
"sAg",
")",
"test",
"or",
"positive",
"test",
"for",
"hepatitis",
"C",
"virus",
"(",
"HCV",
")",
"using",
"HCV",
"ribonucleic",
"acid",
"(",
"RNA",
")",
"or",
"HCV",
"antibody",
"test",
"indicating",
"acute",
"or",
"chronic",
"infection"
] | [
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02132130 | 34:44:treatment | Past serious adverse reaction to anesthesia | 1 | [
"Past",
"serious",
"adverse",
"reaction",
"to",
"anesthesia"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02267863 | 24:49:chronic_disease | Clinically significant intravascular coagulation | 1 | [
"Clinically",
"significant",
"intravascular",
"coagulation"
] | [
0,
0,
2,
2
] |
NCT01681264 | 7:17:treatment, | Takes vitamin B2 > 1.6mg/day during the study | 1 | [
"Takes",
"vitamin",
"B2",
">",
"1.6mg/day",
"during",
"the",
"study"
] | [
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02382549 | 6:22:cancer,60:67:treatment,132:157:treatment | Each brain metastasis must have been completely removed by surgery or each unresected brain metastasis must have been treated with stereotactic radiosurgery | 1 | [
"Each",
"brain",
"metastasis",
"must",
"have",
"been",
"completely",
"removed",
"by",
"surgery",
"or",
"each",
"unresected",
"brain",
"metastasis",
"must",
"have",
"been",
"treated",
"with",
"stereotactic",
"radiosurgery"
] | [
0,
3,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03036098 | 1:43:cancer | Metastatic or inoperable urothelial cancer | 1 | [
"Metastatic",
"or",
"inoperable",
"urothelial",
"cancer"
] | [
3,
3,
3,
3,
3
] |
NCT01459107 | 1:26:treatment | Below-shoulder amputation | 1 | [
"Below-shoulder",
"amputation"
] | [
1,
1
] |
NCT02339233 | 34:57:chronic_disease | stable medical condition without cardiopulmonary disease | 1 | [
"stable",
"medical",
"condition",
"without",
"cardiopulmonary",
"disease"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02549937 | 24:48:chronic_disease,67:74:chronic_disease,75:89:chronic_disease,93:111:chronic_disease,116:133:chronic_disease,151:173:cancer,269:302:chronic_disease,306:317:chronic_disease | History or presence of digestive tract diseases, including active gastric/duodenal ulcer or ulcerative colitis, or active hemorrhage of an unresected gastrointestinal tumor, or an evaluation by investigators of having any other condition that could possibly result in gastrointestinal tract hemorrhage or perforation | 1 | [
"History",
"or",
"presence",
"of",
"digestive",
"tract",
"diseases",
",",
"including",
"active",
"gastric/duodenal",
"ulcer",
"or",
"ulcerative",
"colitis",
",",
"or",
"active",
"hemorrhage",
"of",
"an",
"unresected",
"gastrointestinal",
"tumor",
",",
"or",
"an",
"evaluation",
"by",
"investigators",
"of",
"having",
"any",
"other",
"condition",
"that",
"could",
"possibly",
"result",
"in",
"gastrointestinal",
"tract",
"hemorrhage",
"or",
"perforation"
] | [
0,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT03058783 | 19:36:chronic_disease | Current or recent serious infection | 1 | [
"Current",
"or",
"recent",
"serious",
"infection"
] | [
0,
0,
0,
2,
2
] |
NCT02059239 | ,,,,128:137:treatment | Male and female subjects must use an effective contraceptive method during the study and for a minimum of 6 months after study treatment | 1 | [
"Male",
"and",
"female",
"subjects",
"must",
"use",
"an",
"effective",
"contraceptive",
"method",
"during",
"the",
"study",
"and",
"for",
"a",
"minimum",
"of",
"6",
"months",
"after",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02833792 | 33:41:chronic_disease, | Diagnosed with mild to moderate dementia for at least 3 months prior to enrollment, based on the National Institute of Neurological and Communicative | 1 | [
"Diagnosed",
"with",
"mild",
"to",
"moderate",
"dementia",
"for",
"at",
"least",
"3",
"months",
"prior",
"to",
"enrollment",
",",
"based",
"on",
"the",
"National",
"Institute",
"of",
"Neurological",
"and",
"Communicative"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02094794 | 1:22:treatment,26:61:treatment,, | Echocardiogram (ECHO) or multi gated acquisition scan (MUGA): ejection fraction of >= 50% | 1 | [
"Echocardiogram",
"(",
"ECHO",
")",
"or",
"multi",
"gated",
"acquisition",
"scan",
"(",
"MUGA",
")",
":",
"ejection",
"fraction",
"of",
">",
"=",
"50",
"%"
] | [
1,
1,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02392572 | 51:64:treatment, | Persistent clinically significant toxicities from prior therapy must not be greater than grade 1 | 1 | [
"Persistent",
"clinically",
"significant",
"toxicities",
"from",
"prior",
"therapy",
"must",
"not",
"be",
"greater",
"than",
"grade",
"1"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02549833 | 13:27:treatment,,70:89:treatment,73:89:treatment, | must be off corticosteroid for at least for 2 weeks before the first neoadjuvant vaccine and for at least 2 weeks prior to the first adjuvant vaccine | 1 | [
"must",
"be",
"off",
"corticosteroid",
"for",
"at",
"least",
"for",
"2",
"weeks",
"before",
"the",
"first",
"neoadjuvant",
"vaccine",
"and",
"for",
"at",
"least",
"2",
"weeks",
"prior",
"to",
"the",
"first",
"adjuvant",
"vaccine"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01822522 | ,,,182:194:treatment | men treated or enrolled on this protocol must also agree to use adequate contraception prior to the study, for the duration of study participation, and 6 months after completion of cabozantinib administration | 1 | [
"men",
"treated",
"or",
"enrolled",
"on",
"this",
"protocol",
"must",
"also",
"agree",
"to",
"use",
"adequate",
"contraception",
"prior",
"to",
"the",
"study",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"6",
"months",
"after",
"completion",
"of",
"cabozantinib",
"administration"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02131467 | 1:13:treatment | pioglitazone | 1 | [
"pioglitazone"
] | [
1
] |
NCT02172651 | 25:59:chronic_disease,61:78:chronic_disease,92:121:chronic_disease | Known positive test for human immunodeficiency virus (HIV), hepatitis C virus, or acute or chronic hepatitis B infection | 1 | [
"Known",
"positive",
"test",
"for",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
",",
"hepatitis",
"C",
"virus",
",",
"or",
"acute",
"or",
"chronic",
"hepatitis",
"B",
"infection"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT01919619 | 8:32:chronic_disease | Active congestive heart failure (New York Heart Association [NYHA] class III to IV) | 1 | [
"Active",
"congestive",
"heart",
"failure",
"(",
"New",
"York",
"Heart",
"Association",
"[",
"NYHA",
"]",
"class",
"III",
"to",
"IV",
")"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02429830 | 16:34:treatment,38:46:treatment,48:66:treatment | Subject has an electrical implant or metallic, abdominal implants | 1 | [
"Subject",
"has",
"an",
"electrical",
"implant",
"or",
"metallic",
",",
"abdominal",
"implants"
] | [
0,
0,
0,
1,
1,
0,
1,
0,
1,
1
] |
NCT01697293 | 18:43:cancer,96:105:treatment,109:122:cancer,130:141:treatment | patients who are hormone-receptor positive and who have received other hormonal agents for the treatment of breast cancer (e.g., Fulvestrant) are also eligible | 1 | [
"patients",
"who",
"are",
"hormone-receptor",
"positive",
"and",
"who",
"have",
"received",
"other",
"hormonal",
"agents",
"for",
"the",
"treatment",
"of",
"breast",
"cancer",
"(",
"e.g.",
",",
"Fulvestrant",
")",
"are",
"also",
"eligible"
] | [
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
3,
3,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01614197 | 72:102:treatment | Patients must have fully recovered from the acute toxic effects of all prior anti-cancer chemotherapy | 1 | [
"Patients",
"must",
"have",
"fully",
"recovered",
"from",
"the",
"acute",
"toxic",
"effects",
"of",
"all",
"prior",
"anti-cancer",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02660528 | 12:21:chronic_disease | History of psychosis | 1 | [
"History",
"of",
"psychosis"
] | [
0,
0,
2
] |
NCT02411656 | 45:78:treatment | Is currently participating in a study of an investigational anti-cancer agent | 1 | [
"Is",
"currently",
"participating",
"in",
"a",
"study",
"of",
"an",
"investigational",
"anti-cancer",
"agent"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02579044 | 28:36:chronic_disease | Drugs to treat symptoms of progeria are permitted | 1 | [
"Drugs",
"to",
"treat",
"symptoms",
"of",
"progeria",
"are",
"permitted"
] | [
0,
0,
0,
0,
0,
2,
0,
0
] |
NCT03057730 | 46:69:treatment | Areas that have previously been treated with root coverage surgeries | 1 | [
"Areas",
"that",
"have",
"previously",
"been",
"treated",
"with",
"root",
"coverage",
"surgeries"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02157974 | 1:7:chronic_disease | Anemia | 1 | [
"Anemia"
] | [
2
] |
NCT01666080 | 9:31:chronic_disease | Active, uncontrolled infection | 1 | [
"Active",
",",
"uncontrolled",
"infection"
] | [
0,
0,
2,
2
] |
NCT02389465 | 21:29:chronic_disease | Absence of clinical dementia | 1 | [
"Absence",
"of",
"clinical",
"dementia"
] | [
0,
0,
0,
2
] |
NCT02832687 | 1:16:treatment,20:26:treatment,53:77:chronic_disease | Chronic steroid or opioid user (as prescribed for a chronic systemic illness) | 1 | [
"Chronic",
"steroid",
"or",
"opioid",
"user",
"(",
"as",
"prescribed",
"for",
"a",
"chronic",
"systemic",
"illness",
")"
] | [
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT01532687 | ,32:55:treatment | for 14 days before exposure to investigational product, through the dosing period | 1 | [
"for",
"14",
"days",
"before",
"exposure",
"to",
"investigational",
"product",
",",
"through",
"the",
"dosing",
"period"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02968446 | 18:30:treatment,32:42:treatment,44:58:treatment,60:73:treatment,75:84:treatment,89:100:treatment | Currently taking ketoconazole, colestipol, cholestyramine, phenobarbitol, phenytoin, or mineral oil | 1 | [
"Currently",
"taking",
"ketoconazole",
",",
"colestipol",
",",
"cholestyramine",
",",
"phenobarbitol",
",",
"phenytoin",
",",
"or",
"mineral",
"oil"
] | [
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02236013 | 49:85:cancer, | Subject has a diagnosis of previously-untreated de novo acute myeloid leukemia (AML) according to WHO classification (2008) documented within 28 days prior to enrollment | 1 | [
"Subject",
"has",
"a",
"diagnosis",
"of",
"previously-untreated",
"de",
"novo",
"acute",
"myeloid",
"leukemia",
"(",
"AML",
")",
"according",
"to",
"WHO",
"classification",
"(",
"2008",
")",
"documented",
"within",
"28",
"days",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02366871 | 1:6:treatment,11:16:treatment,25:50:treatment | SSRIs and SNRIs (common anti-depressant therapies) | 1 | [
"SSRIs",
"and",
"SNRIs",
"(",
"common",
"anti-depressant",
"therapies",
")"
] | [
1,
0,
1,
0,
0,
1,
1,
0
] |
NCT03008070 | 1:33:cancer | cutaneous basocellular carcinoma | 1 | [
"cutaneous",
"basocellular",
"carcinoma"
] | [
3,
3,
3
] |
NCT02390752 | 9:18:treatment,34:48:treatment,52:73:treatment,100:112:treatment,117:125:cancer | Ongoing treatment with any other cancer therapy or investigational agent, with the exception of IT chemotherapy for leukemia, when indicated | 1 | [
"Ongoing",
"treatment",
"with",
"any",
"other",
"cancer",
"therapy",
"or",
"investigational",
"agent",
",",
"with",
"the",
"exception",
"of",
"IT",
"chemotherapy",
"for",
"leukemia",
",",
"when",
"indicated"
] | [
0,
1,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
3,
0,
0,
0
] |
NCT02462590 | 41:71:chronic_disease,134:151:chronic_disease,165:168:chronic_disease,,212:241:treatment,249:261:treatment,263:275:treatment,277:293:treatment,295:305:treatment,307:319:treatment,321:333:treatment,335:343:treatment,346:370:treatment,382:391:treatment,406:416:cancer,427:439:treatment,,462:473:chronic_disease,,,538:553:treatment | Patients at potential increased risk of iatrogenic probiotic infection (see Section 2.6 for detailed explanation) including specific immunocompromised populations (HIV <200 CD4 cells/μL, those receiving chronic immunosuppressive medications (e.g., azathioprine, cyclosporine, cyclophosphamide, tacrolimus, methotrexate, mycofenolate, Anti-IL2), previous transplantation (including stem cell) at any time, malignancy requiring chemotherapy in the last 3 months, neutropenia [absolute neutrophil count < 500]). However, patients receiving corticosteroids previously or presently or projected to receive corticosteroids are not excluded | 1 | [
"Patients",
"at",
"potential",
"increased",
"risk",
"of",
"iatrogenic",
"probiotic",
"infection",
"(",
"see",
"Section",
"2.6",
"for",
"detailed",
"explanation",
")",
"including",
"specific",
"immunocompromised",
"populations",
"(",
"HIV",
"<",
"200",
"CD4",
"cells/μL",
",",
"those",
"receiving",
"chronic",
"immunosuppressive",
"medications",
"(",
"e.g.",
",",
"azathioprine",
",",
"cyclosporine",
",",
"cyclophosphamide",
",",
"tacrolimus",
",",
"methotrexate",
",",
"mycofenolate",
",",
"Anti-IL2",
")",
",",
"previous",
"transplantation",
"(",
"including",
"stem",
"cell",
")",
"at",
"any",
"time",
",",
"malignancy",
"requiring",
"chemotherapy",
"in",
"the",
"last",
"3",
"months",
",",
"neutropenia",
"[",
"absolute",
"neutrophil",
"count",
"<",
"500",
"]",
")",
".",
"However",
",",
"patients",
"receiving",
"corticosteroids",
"previously",
"or",
"presently",
"or",
"projected",
"to",
"receive",
"corticosteroids",
"are",
"not",
"excluded"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0,
1,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01293214 | 25:49:treatment | Single dominant hand or multiple limb amputation | 1 | [
"Single",
"dominant",
"hand",
"or",
"multiple",
"limb",
"amputation"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT02008136 | 1:19:chronic_disease | myotonic dystrophy | 1 | [
"myotonic",
"dystrophy"
] | [
2,
2
] |
NCT01730937 | 1:4:chronic_disease,, | HIV positive with CD4 count < (350) cells/microliter | 1 | [
"HIV",
"positive",
"with",
"CD4",
"count",
"<",
"(",
"350",
")",
"cells/microliter"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03162731 | 8:19:chronic_disease | active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) | 1 | [
"active",
"hepatitis",
"B",
"(",
"e.g.",
",",
"hepatitis",
"B",
"surface",
"antigen",
"[",
"HBsAg",
"]",
"reactive",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03120728 | 24:46:treatment | history of complicated solid organ transplant | 1 | [
"history",
"of",
"complicated",
"solid",
"organ",
"transplant"
] | [
0,
0,
0,
1,
1,
1
] |
NCT02913612 | 29:51:chronic_disease | Hemodynamically significant cardiovascular disease, as determined by the investigator | 1 | [
"Hemodynamically",
"significant",
"cardiovascular",
"disease",
",",
"as",
"determined",
"by",
"the",
"investigator"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT03030118 | 78:124:treatment, | Starting, stopping, or changing the dose of over the counter or prescription non-steroidal anti-inflammatory drugs (NSAIDs) in the three months prior to Visit 1 | 1 | [
"Starting",
",",
"stopping",
",",
"or",
"changing",
"the",
"dose",
"of",
"over",
"the",
"counter",
"or",
"prescription",
"non-steroidal",
"anti-inflammatory",
"drugs",
"(",
"NSAIDs",
")",
"in",
"the",
"three",
"months",
"prior",
"to",
"Visit",
"1"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02203513 | ,147:159:treatment | Patients should have recurrent platinum-resistant, defined as disease recurrence by imaging within 6 months of the last receipt of platinum-based chemotherapy | 1 | [
"Patients",
"should",
"have",
"recurrent",
"platinum-resistant",
",",
"defined",
"as",
"disease",
"recurrence",
"by",
"imaging",
"within",
"6",
"months",
"of",
"the",
"last",
"receipt",
"of",
"platinum-based",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02179853 | 12:44:chronic_disease | History of tuberculosis (TB) or TB exposure | 1 | [
"History",
"of",
"tuberculosis",
"(",
"TB",
")",
"or",
"TB",
"exposure"
] | [
0,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02562755 | 1:25:chronic_disease, | congestive heart failure within the preceding 12 months | 1 | [
"congestive",
"heart",
"failure",
"within",
"the",
"preceding",
"12",
"months"
] | [
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT03028012 | 1:13:chronic_disease | Fibromyalgia | 1 | [
"Fibromyalgia"
] | [
2
] |
NCT02664909 | 12:30:chronic_disease | history of pulmonary embolism | 1 | [
"history",
"of",
"pulmonary",
"embolism"
] | [
0,
0,
2,
2
] |
NCT01895777 | 88:95:allergy_name | Patients who are allergic/sensitive to any component of the study medication including solvent | 1 | [
"Patients",
"who",
"are",
"allergic/sensitive",
"to",
"any",
"component",
"of",
"the",
"study",
"medication",
"including",
"solvent"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT02106650 | 21:55:chronic_disease | known, uncontrolled human immunodeficiency virus (HIV)-positive diagnosis | 1 | [
"known",
",",
"uncontrolled",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"-positive",
"diagnosis"
] | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02391987 | 1:20:chronic_disease,22:31:chronic_disease,35:40:chronic_disease | shortness of breath, orthopnea or edema | 1 | [
"shortness",
"of",
"breath",
",",
"orthopnea",
"or",
"edema"
] | [
2,
2,
2,
0,
2,
0,
2
] |
NCT02370693 | ,,,,58:71:treatment | Fall in FVC > 10% over 6 months on at least 12 months of prior therapy | 1 | [
"Fall",
"in",
"FVC",
">",
"10",
"%",
"over",
"6",
"months",
"on",
"at",
"least",
"12",
"months",
"of",
"prior",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT00948285 | 15:34:chronic_disease,,,73:103:chronic_disease,131:141:treatment | Patients with renal insufficiency (serum Cr > 1.5) due to the danger of nephrogenic systemic sclerosis with the administration of Gadolinium | 1 | [
"Patients",
"with",
"renal",
"insufficiency",
"(",
"serum",
"Cr",
">",
"1.5",
")",
"due",
"to",
"the",
"danger",
"of",
"nephrogenic",
"systemic",
"sclerosis",
"with",
"the",
"administration",
"of",
"Gadolinium"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
1
] |